KPMG LLP, under contract with the Department of Homeland Security OIG, issued an Independent Accountants’ Report on the U.S. Customs and Border Protection’s (CBP) fiscal year 2015 Drug Control Performance Summary Report. CBP’s management prepared the Performance Summary Report and related disclosures to comply with the requirements of the ONDCP Circular, Accounting of Drug Control Funding and Performance Summary, dated January 18, 2013 (Circular). Based on its review, nothing came to KPMG LLP’s attention that caused it to believe that CBP’s FY 2015 Performance Summary Report is not presented in conformity with the criteria in the ONDCP Circular. KPMG LLP did not make any recommendations as a result of its review.
Consistent with CDC guidance, most Office of Inspector General employees are currently serving the American people remotely. We are determined to keep interruptions to our operations to a minimum, and we appreciate your patience during this time.
Information and guidance about COVID-19 is available at coronavirus.gov.